| http://www.w3.org/ns/prov#value | - The only currently FDA-approved regimen for treatment-resistant depression is the olanzapine/fluoxetine combination, whereas aripiprazole and quetiapine are approved as adjunctive agents.65-67 The atypical antipsychotics are associated with a variety of relatively serious adverse effects, such as dyskinesia and neuroleptic malignant syndrome.65-67 Herbal Therapy (St. John???s Wort) for Depression
|
